March 9, 2020
Sysmex Corporation
Announcement of Organizational and Personnel Changes
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) announces today its decision to implement organizational and personnel changes, effective April 1, 2020, as detailed below. Targeting sustainable growth for the Group, the organizational changes aim to enhance the business development structure to accelerate strategy deployment and reinforce the Group's governance structure to enhance management quality.
1. Organizational Changes
- Reinforcing the Business Development Structure
- Augmenting Functions Related to Sales, Services and IT Products Leveraging Next- Generation Information Technologies
- We will establish the Caresphere Innovation Division to spearhead planning and promotion with a view to fostering digital innovation in the sales, service and IT domains by leveraging our Caresphere™ network solution.
- Strengthening Clinical Development Capabilities in the Life Science (LS) Field
- In the aim of accelerating the provision of products and services with new diagnostic technologies, we will establish the LS Medical Affairs Division within the LS Business Unit. The new division will strategically plan and promote clinical performance testing within the scope of obtaining approval to manufacture and sell in vitro diagnostic pharmaceuticals (regulatory approval).
- Buttressing the Global Governance Structure
- Reinforcing the Group Governance Function to Enhance Management Quality
- To realize a governance function that responds to a rapidly changing environment, we will integrate the internal control and risk management functions and establish the Internal Control Division as the entity dedicated to these functions.
Organizational Structure (Changes are in red.)
Organizational Structure (FY2019)
2. Personnel Changes and Appointments | ||||
(1) | Appointments of Senior Executive Officers (Promotions) | |||
Name | New Position | Current Position | ||
Tomokazu | Senior Executive Officer | Executive Officer | ||
Yoshida | ||||
Kensuke Iizuka | Senior Executive Officer | Executive Officer | ||
(2) | Appointments of Executive Officers (Newly Appointed) | |||
Name | New Position | Current Position | ||
Alain Baverel | Executive Officer | CEO, Sysmex Europe GmbH | ||
(3) | Retirement of Executive Officers (Completion of Contract Term) | |||
Name | New Position | Current Position | ||
John Kershaw | ― | Senior Executive Officer | ||
(4) Changes in Operating and Functional Changes of Executive Officers
Name | New Position | Current Position |
Kaoru Asano | Member of the Managing Board and | Member of the Managing Board and |
Senior Executive Officer | Senior Executive Officer | |
Senior Managing Director | Senior Managing Director | |
COO LS Business Unit(*1) and CTO | COO LS Business Unit and CTO | |
In charge of Corporate R&D(*2) | In charge of; | |
Vice President of | LS Business Div. | |
Medicaroid Corporation | Clinical Innovation Div. | |
LS Business Development Dept. | ||
LS Medical Affairs Dept. | ||
Technology Strategy Div. | ||
Central Research Laboratories | ||
System Technologies Laboratory | ||
Bio-Diagnostic Reagent Technology | ||
Center | ||
Intellectual Property Div. | ||
Scientific Affairs Div. | ||
MR Business Development Div. | ||
Medicaroid Corporation | ||
Sysmex Engineering Co., Ltd. | ||
Creative Nanosystems Corporation | ||
Sysmex R&D Center Europe GmbH | ||
Vice President of | ||
Medicaroid Corporation | ||
Kenji | Member of the Managing Board and | Member of the Managing Board and |
Tachibana | Senior Executive Officer | Senior Executive Officer |
Senior Managing Director | Senior Managing Director | |
COO IVD Business Unit(*3) | COO IVD Business Unit | |
In charge of; | ||
Business Strategy Development Div. | ||
HU Business Development Div. | ||
ICH Business Development Div. | ||
Engineering 1 Div. | ||
Engineering 2 Div. | ||
JEA Region Div. | ||
Sales and Marketing East / Japan Div. | ||
Sales and Marketing West / Japan Div. | ||
Global Support Div. | ||
Technology HR Development Dept. | ||
Development Administration Dept. | ||
Iwane Matsui | Member of the Managing Board and | Member of the Managing Board and |
Senior Executive Officer | Senior Executive Officer | |
Managing Director | Managing Director | |
In charge of Japan and | In charge of; | |
International Business(*4) | JEA Region Div. | |
Sales and Marketing East / Japan Div. | ||
Sales and Marketing West / Japan Div. | ||
Global Support Div. | ||
Sysmex TMC Co., Ltd. | ||
Sysmex CNA Co., Ltd. | ||
Sysmex America, Inc. | ||
Sysmex Europe GmbH | ||
Sysmex Shanghai Ltd. | ||
Sysmex Asia Pacific Pte Ltd. | ||
Sysmex Korea Co., Ltd. | ||
Sysmex Taiwan Co., Ltd. |
Name | New Position | Current Position |
Hiroshi Kanda | Member of the Managing Board and | Member of the Managing Board and |
Senior Executive Officer | Senior Executive Officer | |
Managing Director | Managing Director | |
IVD Business Unit | IVD Business Unit | |
In charge of IVD Business(*5) | In charge of; | |
Business Strategy Development Div. | ||
HU Business Development Div. | ||
ICH Business Development Div. | ||
Sysmex Partec GmbH | ||
HYPHEN BioMed, SAS | ||
Sysmex Wuxi Co., Ltd. | ||
Mamoru | Senior Executive Officer | Senior Executive Officer |
Kubota | LS Business Unit | LS Business Unit |
In charge of LS Business(*6) | In charge of; | |
LS Business Div. | ||
Clinical Innovation Div. | ||
LS Business Development Dept. | ||
LS Medical Affairs Dept. | ||
RIKEN GENESIS CO., LTD. | ||
Sysmex Inostics GmbH | ||
Oxford Gene Technology IP Limited | ||
Tomokazu | Senior Executive Officer | Executive Officer |
Yoshida | Executive Vice President of | Executive Vice President of |
Central Research Laboratories, | Central Research Laboratories, | |
MR Business Development | MR Business Development | |
Director of Medicaroid Corporation | Director of Medicaroid Corporation | |
Kensuke Iizuka | Senior Executive Officer | Executive Officer |
Deputy in charge of | Deputy in charge of; | |
Corporate Staff(*7) | Human Resources Div. | |
General Affairs Div. | ||
Sysmex Business Support Co., Ltd. | ||
Sysmex Harmony Co., Ltd. | ||
Executive Vice President of | ||
Human Resources Div. | ||
Frank | Executive Officer | Executive Officer |
Buescher | CEO, Sysmex Asia Pacific Pte Ltd. | CEO, Sysmex Asia Pacific Pte Ltd. |
Executive Vice President of | ||
Caresphere Innovation Div. | ||
Alain Baverel | Executive Officer | CEO, Sysmex Europe GmbH |
CEO, Sysmex Europe GmbH | ||
- LS Business Div., Clinical Innovation Div., LS Medical Affairs Div., LS Business Development Dept.
- Technology Strategy Div., Central Research Laboratories, System Technologies Laboratory, Bio-Diagnostic Reagent Technology Center, Intellectual Property Div., Scientific Affairs Div., MR Business Development Div. Medicaroid Corporation, Sysmex Engineering Co.,Ltd., Creative Nanosystems Corporation, Sysmex R&D Center Americas, Inc., Sysmex R&D Center Europe GmbH
- Business Strategy Development Div., HU Business Development Div., ICH Business Development Div., Caresphere Innovation Div., Engineering 1 Div., Engineering 2 Div., JEA Region Div., Sales and Marketing East / Japan Div., Sales and Marketing West / Japan Div., Global Support Div., Technology HR Development Dept., Development Administration Dept.
- JEA Region Div., Sales and Marketing East / Japan Div., Sales and Marketing West / Japan Div., Global Support Div.
Sysmex TMC Co., Ltd., Sysmex CNA Co., Ltd., Sysmex America, Inc., Sysmex Europe GmbH, Sysmex Shanghai
Ltd., Sysmex Asia Pacific Pte Ltd., Sysmex Korea Co., Ltd., Sysmex Taiwan Co., Ltd.
-
Business Strategy Development Div., HU Business Development Div., ICH Business Development Div., Caresphere Innovation Div.
Sysmex Partec GmbH, Sysmex CNA Co., Ltd., Sysmex New Zealand Ltd., HYPHEN BioMed, SAS, Sysmex Wuxi Co., Ltd - LS Business Div., Clinical Innovation Div., LS Medical Affairs Div., LS Business Development Dept., RIKEN GENESIS CO., LTD., Sysmex Inostics GmbH, Oxford Gene Technology IP Limited
- Corporate Business Planning Div., Corporate Communication Div., Corporate Business Administration Div., Human Resources Div., General Affairs Div., Corporate Executive Office
Sysmex Business Support Co., Ltd., Sysmex Harmony Co., Ltd.
Attachments
- Original document
- Permalink
Disclaimer
Sysmex Corporation published this content on 09 March 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 March 2020 06:32:04 UTC